Millennium Management

Millennium Management’s enGene Therapeutics Warrants ENGNW Stock Holding History

Millennium Management’s Portfolio ENGNW Stock Details ENGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$175K	Hold	69,000	–	–	﹤0.01%	5223
2025 Q4	$204K	Hold	69,000	–	–	﹤0.01%	5468
2025 Q3	$49K	Hold	69,000	–	–	﹤0.01%	5805
2025 Q2	$56.6K	Hold	69,000	–	–	﹤0.01%	5597
2025 Q1	$41.4K	Hold	69,000	–	–	﹤0.01%	5561
2024 Q4	$58.2K	Hold	69,000	–	–	﹤0.01%	5570
2024 Q3	$145K	Hold	69,000	–	–	﹤0.01%	5518
2024 Q2	$95.9K	Hold	69,000	–	–	﹤0.01%	5318
2024 Q1	$359K	Hold	69,000	–	–	﹤0.01%	5028
2023 Q4	$58.6K	Buy	+69,000	New	+$53K	﹤0.01%	5446

Other funds holding ENGNW

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return